Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1992 Nov;141(5):1031–1036.

Interleukin-4 may contribute to the abundant T-cell reaction and paucity of neoplastic B cells in T-cell-rich B-cell lymphomas.

W R Macon 1, J B Cousar 1, J A Waldron Jr 1, S M Hsu 1
PMCID: PMC1886680  PMID: 1443042

Abstract

T-cell-rich B-cell lymphomas (TCRBCLs) are diffuse lymphomas that contain a minority of large neoplastic B cells amidst a majority of non-neoplastic T cells and numerous histiocytes, an unusually pronounced reactive component not seen in most diffuse large B-cell lymphomas (DLBCLs). This reaction may be influenced by various cytokines secreted by lymphoma or reactive cells; therefore, expression of interleukin (IL)-1 beta, IL-2, IL-4, IL-6, and IL-9 was evaluated immunohistochemically on paraffin-embedded sections of 18 TCRBCLs and was compared with that of 15 DLBCLs containing a minority of reactive T cells and to that of seven reactive lymph nodes. Moderate to intense expression of IL-4 was detected in variable numbers of tumor cells and in numerous histiocytes in 16 TCRBCLs. In contrast, intense IL-4 expression in numerous histiocytes was observed in only one of 15 DLBCLs with few T cells. In four other DLBCLs and three reactive nodes, moderate to intense staining for IL-4 was noted only in rare large transformed cells or in occasional histiocytes. Except for one IL-1 beta positive and another IL-9 positive TCRBCL, there was no marking or weak staining only with other cytokine antibodies in the neoplastic and reactive cases studied. The expression of IL-4 in most TCRBCLs, but not in other DLBCLs or in reactive nodes, suggests that this cytokine is one factor involved in the pathobiology of the abundant T-cell reaction and, perhaps, contributes to the paucity of neoplastic B cells in TCRBCLs.

Full text

PDF
1031

Images in this article

1033Figure 1
on p.1033
1034Figure 2
on p.1034

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balkwill F. R., Burke F. The cytokine network. Immunol Today. 1989 Sep;10(9):299–304. doi: 10.1016/0167-5699(89)90085-6. [DOI] [PubMed] [Google Scholar]
  2. Ben-Sasson S. Z., Le Gros G., Conrad D. H., Finkelman F. D., Paul W. E. IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J Immunol. 1990 Aug 15;145(4):1127–1136. [PubMed] [Google Scholar]
  3. Biondi A., Rossi V., Bassan R., Barbui T., Bettoni S., Sironi M., Mantovani A., Rambaldi A. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood. 1989 Apr;73(5):1279–1284. [PubMed] [Google Scholar]
  4. Cordingley F. T., Bianchi A., Hoffbrand A. V., Reittie J. E., Heslop H. E., Vyakarnam A., Turner M., Meager A., Brenner M. K. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet. 1988 Apr 30;1(8592):969–971. doi: 10.1016/s0140-6736(88)91782-5. [DOI] [PubMed] [Google Scholar]
  5. Defrance T., Fluckiger A. C., Rossi J. F., Magaud J. P., Sotto J. J., Banchereau J. Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood. 1992 Feb 15;79(4):990–996. [PubMed] [Google Scholar]
  6. Duprez V., Lenoir G., Dautry-Varsat A. Autocrine growth stimulation of a human T-cell lymphoma line by interleukin 2. Proc Natl Acad Sci U S A. 1985 Oct;82(20):6932–6936. doi: 10.1073/pnas.82.20.6932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 1991 Aug;5(11):2567–2574. doi: 10.1096/fasebj.5.11.1868981. [DOI] [PubMed] [Google Scholar]
  8. Gootenberg J. E., Ruscetti F. W., Mier J. W., Gazdar A., Gallo R. C. Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med. 1981 Nov 1;154(5):1403–1418. doi: 10.1084/jem.154.5.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hsu P. L., Hsu S. M. Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2. Am J Pathol. 1989 Oct;135(4):735–745. [PMC free article] [PubMed] [Google Scholar]
  10. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  11. Hsu S. M., Zhao X. Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies. Am J Pathol. 1986 Nov;125(2):221–225. [PMC free article] [PubMed] [Google Scholar]
  12. Jücker M., Abts H., Li W., Schindler R., Merz H., Günther A., von Kalle C., Schaadt M., Diamantstein T., Feller A. C. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood. 1991 Jun 1;77(11):2413–2418. [PubMed] [Google Scholar]
  13. Kadin M. E., Agnarsson B. A., Ellingsworth L. R., Newcom S. R. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. Am J Pathol. 1990 Jun;136(6):1209–1214. [PMC free article] [PubMed] [Google Scholar]
  14. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988 Mar 3;332(6159):83–85. doi: 10.1038/332083a0. [DOI] [PubMed] [Google Scholar]
  15. Macon W. R., Williams M. E., Greer J. P., Stein R. S., Collins R. D., Cousar J. B. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am J Surg Pathol. 1992 Apr;16(4):351–363. [PubMed] [Google Scholar]
  16. Merz H., Fliedner A., Lehrnbecher T., Sebald W., Müller-Hermelink H. K., Feller A. C. Cytokine expression in B-cell non-Hodgkin lymphomas. Hematol Oncol. 1990 Nov-Dec;8(6):355–361. doi: 10.1002/hon.2900080608. [DOI] [PubMed] [Google Scholar]
  17. Merz H., Houssiau F. A., Orscheschek K., Renauld J. C., Fliedner A., Herin M., Noel H., Kadin M., Mueller-Hermelink H. K., Van Snick J. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 1991 Sep 1;78(5):1311–1317. [PubMed] [Google Scholar]
  18. Ohnishi K., Ichikawa A., Kagami Y., Nagasaka T., Niwa T., Hotta T., Saito H. Interleukin 4 and gamma-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma. Cancer Res. 1990 Dec 15;50(24):8028–8033. [PubMed] [Google Scholar]
  19. Osborne B. M., Butler J. J., Pugh W. C. The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: lineage confirmed by JH rearrangement. Am J Surg Pathol. 1990 Oct;14(10):933–938. doi: 10.1097/00000478-199010000-00006. [DOI] [PubMed] [Google Scholar]
  20. Paul W. E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991 May 1;77(9):1859–1870. [PubMed] [Google Scholar]
  21. Peuchmaur M., Emilie D., Crevon M. C., Brousse N., Gaulard P., D'Agay M. F., Galanaud P., Solal-Celigny P. Interleukin-2 and interferon-gamma production in follicular lymphomas. Am J Clin Pathol. 1991 Jan;95(1):55–62. doi: 10.1093/ajcp/95.1.55. [DOI] [PubMed] [Google Scholar]
  22. Ramsay A. D., Smith W. J., Isaacson P. G. T-cell-rich B-cell lymphoma. Am J Surg Pathol. 1988 Jun;12(6):433–443. doi: 10.1097/00000478-198806000-00003. [DOI] [PubMed] [Google Scholar]
  23. Sander B., Cardell S., Heremans H., Andersson U., Möller G. Detection of individual interleukin 4- and gamma interferon-producing murine spleen cells after activation with T-cell mitogens. Scand J Immunol. 1989 Sep;30(3):315–320. doi: 10.1111/j.1365-3083.1989.tb01216.x. [DOI] [PubMed] [Google Scholar]
  24. Seder R. A., Le Gros G., Ben-Sasson S. Z., Urban J., Jr, Finkelman F. D., Paul W. E. Increased frequency of interleukin 4-producing T cells as a result of polyclonal priming. Use of a single-cell assay to detect interleukin 4-producing cells. Eur J Immunol. 1991 May;21(5):1241–1247. doi: 10.1002/eji.1830210522. [DOI] [PubMed] [Google Scholar]
  25. Shimizu S., Hirano T., Yoshioka R., Sugai S., Matsuda T., Taga T., Kishimoto T., Konda S. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood. 1988 Nov;72(5):1826–1828. [PubMed] [Google Scholar]
  26. Sideras P., Funa K., Zalcberg-Quintana I., Xanthopoulos K. G., Kisielow P., Palacios R. Analysis by in situ hybridization of cells expressing mRNA for interleukin 4 in the developing thymus and in peripheral lymphocytes from mice. Proc Natl Acad Sci U S A. 1988 Jan;85(1):218–221. doi: 10.1073/pnas.85.1.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Swain S. L., McKenzie D. T., Weinberg A. D., Hancock W. Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol. 1988 Nov 15;141(10):3445–3455. [PubMed] [Google Scholar]
  28. Taylor C. W., Grogan T. M., Salmon S. E. Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood. 1990 Mar 1;75(5):1114–1118. [PubMed] [Google Scholar]
  29. Zuber C. E., Galizzi J. P., Vallé A., Harada N., Howard M., Banchereau J. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation. Eur J Immunol. 1990 Mar;20(3):551–555. doi: 10.1002/eji.1830200314. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES